Mepolizumab
CAS No. 196078-29-2
Mepolizumab( SB 240563 )
Catalog No. M28987 CAS No. 196078-29-2
Mepolizumab is a humanized monoclonal antibody neutralizing IL-5. Mepolizumab can be used in studies about severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 758 | Get Quote |
|
| 10MG | 1044 | Get Quote |
|
| 25MG | 1557 | Get Quote |
|
| 50MG | 2097 | Get Quote |
|
| 100MG | 2817 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMepolizumab
-
NoteResearch use only, not for human use.
-
Brief DescriptionMepolizumab is a humanized monoclonal antibody neutralizing IL-5. Mepolizumab can be used in studies about severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis.
-
DescriptionMepolizumab is a humanized monoclonal antibody neutralizing IL-5. Mepolizumab can be used in studies about severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis.
-
In Vitro——
-
In Vivo——
-
SynonymsSB 240563
-
PathwayApoptosis
-
TargetIL Receptor
-
RecptorAdenine phosphoribosyltransferase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number196078-29-2
-
Formula Weight——
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Borrmann T, et al. Structure-activity relationships of adenine and deazaadenine derivatives as ligands for adenine receptors, a new purinergic receptor family. J Med Chem. 2009 Oct 8;52(19):5974-89.
molnova catalog
related products
-
5-O-Caffeoylshikimic...
5-O-Caffeoylshikimic acid shows anti-oxidative activity; it also shows anti-inflammatory activity, the underlying mechanism was associated with downregulation of nuclear factor-κB.
-
Daclizumab
Daclizumab (Zenapax) is a humanized monoclonal antibody that specifically inhibits the alpha subunit of IL-2R-HA.
-
Ordesekimab
Ordesekimab (AMG 714) is a human IgG1 κ-anti-IL-15 (Interleukin Related) monoclonal antibody.
Cart
sales@molnova.com